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effect. The compensators being close to the patient and interfering 
with the beam is a source of concern as it may be the source for 
secondary cancers in the patient. The use of scanned proton beams 
however avoids this problem. We have recently introduced a magnetic 
scanning option to the Sumitomo proton system. The current abstract 
covers the description of this system and reports the first 
measurements. 
Materials and Methods: A set of scanning magnets, positioned 
downstreams of the bending magnet, scans the beam in the x- and y-
direction. The system is capable of several techniques for scanning 
the beam, i.e. spot scanning, line scanning as well as variable 
scanning. A maximum field size of 30x40 cm can be generated with a 
dedicated nozzle. The characteristics of the scanning system have 
been verified in a clinical setting using line scanning with a proton 
pencil beam having dimensions of σx=3.6 mm and σy=4.0 mm. 
Results: The maximum range in water is 32 g/cm2 and the dose rate is 
limited to 1 Gy/min/litre irradiated volume, regardless of depth. For 
a simple field the dose uniformity is 2.5 % inside 80 % of the field size 
using the line scanning delivery mode. The lateral penumbra is 8.5 
mm at 230 MeV. 
Conclusions: The proton scanning system is capable of replacing the 
scattered beam delivery mode effectively. High dose rate and fast 
layer switching is used for optimal conformity. The full field can be 
delivered with many re-paintings at all layers, even within one breath-
hold. To utilize the full extent of the scanning beam system a 
treatment planning system should be used for the purpose of 
optimizing the dose distribution using the various parameters that can 
be optimized. 
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Purpose/Objective: At the Heidelberg Ion-Beam Therapy Center (HIT) 
patients are treated with scanned protons and carbon ions. Until fall 
2012, the facility had two treatment rooms in operation and more 
than 1000 patients were treated. The fixed horizontal beam lines in 
these rooms limit the available beam directions. To overcome this, in 
summer 2012 the world's first heavy ion gantry was commissioned for 
patient treatment. The gantry allows rotation of the beam line in 
360º, offering the same beam directions available in conventional 
radiotherapy gantries. First patients were treated with the gantry on 
November 19th. The gantry carries the complete beam line for high 
energy ions (large bending magnets, vacuum, imaging, IT and cooling 
systems) and has a total mass of 670t. Furthermore, the treatment 
room is built into the gantry structure and rotates during therapy. This 
leads to structural deformations at different gantry angles, which 
affect all devices related to patient position. To achieve the precise 
positioning required for ion-beam therapy, position deviations had to 
be assessed and an overall concept for patient positioning hat to be 
developed and verified. 
Materials and Methods: To determine the range and reproducibility of 
position deviations, the motion of treatment table, lasers and imaging 
system was measured at different gantry angles. Using a tracking laser 
interferometer, positions of the respective devices were measured in 
a fixed coordinate system unaffected by gantry motion. Cross checks 
were done with a three axis translation stage. Based on these 
measurements, appropriate corrections were introduced to the 
patient positioning and ion-beam adjustment. Their correct 
application was verified using geometric phantoms (both commercial 
and in-house-developed). 
Results: The co-rotating laser system was not reliable at angles 
different from 0º. During gantry rotation, the treatment table showed 
reproducible translations below ±1 mm and negligible rotations. The 
imaging system showed a reproducible misalignment of up to 1.2 mm 
and 0.5º. These deviations were outside our specifications. After 
implementation of corrections, verification measurements showed 
positioning errors within our tolerance limits of ±0.5 mm and 0.5º. 
Conclusions: In the course of commissioning, the relative movement 
of each component relevant to patient positioning was measured after 
gantry rotation. Based on these results a procedure for gantry angle 
dependent positioning was conceived, where the patient defines the 
isocenter: 
- Lasers indicate the isocenter only during setup at gantry angle 0º. 
- The ion beam follows the gantry angle dependent motion of the 
treatment table and patient via angle dependent calibration of the 
beam monitoring system. 
- Misalignment of X-ray imagers and detectors is corrected by applying 
an angle dependent 6 degrees of freedom correction to the patient's 
CT dataset during position verification.  
These procedures allow a positioning of the patient at the beam 
isocenter with an overall accuracy of ±0.5 mm.  
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Purpose/Objective: Electron radiotherapy is being revived by the fact 
that add-on electron multileaf collimators (EMLC) are faster and more 
efficient than common applicators and customized cut-outs in shaping 
the beams, thus achieving more efficient dose delivery. This work 
presents the results of some clinical applications of a commercial add-
on EMLC. In particular, the simplified workflow is described for 
clinically prescribed electron treatments of skin lesions. Additionally, 
plan comparisons with conventional applicators are presented for 
common cases of shallow tumours. 
Materials and Methods: The EMLC consists of 60 separately calibrated 
and controlled brass leaves with a physical leaf width of 0.6 cm, 
placed 16 cm above the isocenter. Their positioning is performed 
using a portable computer. Prior to clinical applications, the EMLC was 
implemented in our treatment planning system and accurately 
commissioned. In this work, two cases of patients with skin lesions are 
presented to describe the simplified workflow when electron field 
shapes are prescribed clinically. The first patient was treated a few 
hours after surgical removal of keloids, while the second case shows 
the re-irradiation of a patient affected by mycosis fungoides. 
Moreover, treatment plans of two patients with shallow tumours 
calculated for the EMLC are presented here and compared to those 
obtained with conventional applicators. The first plan is the one of a 
patient with a rib metastasis, treated with 12 MeV electrons. The 
second plan concerns a patient receiving whole-breast photon 
irradiation of both breasts and a boost in the tumour bed with 10 MeV 
electrons. The Monte Carlo treatment plans were calculated by using 
Oncentra Masterplan (Version 3.3.1.3).  
Results: For both ad-hoc patients, six electron fields were shaped 
inside the treatment room shortly before irradiation, keeping the 
overall treatment time below one hour. The dose prescription for 
these irregular fields was verified after the first fraction with 
Gafchromic Films and the maximum discrepancy between expected 
and measured dose was approximately 5%. In the case of breast 
irradiation, the applicators and the EMLC generate comparable PTV 
dose coverage, although the mean dose produced with the EMLC is 
about 4% lower. The EMLC mean dose to the lungs is about 20% higher 
than the one with the applicator. Also in the case of the rib 
metastasis, the dose conformance obtained with the EMLC was 
comparable to the one generated by the common applicator. In both 
plans, due to a larger penumbra, the margins for defining the 
aperture with the EMLC were about 3 mm broader than those used for 
conventional cut-outs.  
Conclusions: We conclude that the simplified workflow in the clinical 
routine and the satisfactory tumour coverage encourage the use of the 
EMLC for fixed-beam electron therapy. These results represent a first 
step towards the clinical implementation of electron IMRT. 
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Purpose/Objective: To develop an MRI-guided procedure for the 
treatment planning and patient setup verification of liver SBRT 
tailored for a hybrid linac-MR on rails system. 
Materials and Methods: At our institution, an MR-guided therapy 
system consisting of a Varian TrueBeam 6X linac and a 1.5T Siemens 
Espree MR scanner is under development and scheduled to become 
operational next year. The MR scanner can travel on rails (solution by 
IMRIS, Canada) between the MR suite (purpose: simulation/planning) 
and the immediately adjacent linac vault (purpose: patient setup 
verification), the two rooms being separated by radiation shielding 
doors. In the treatment room, the patient is transferred between the 
MR and linac isocenters via a robotic couch. The operation of the 
system is designed to be sequential: a) the MR moves to a pre-defined 
location, in the close proximity of the linac (parked and in stand-by), 
imaging is performed and the MR returns to the simulation room, and 
b) the patient couch translates to the linac which resumes its 
operation (imaging and/or treatment delivery). One of the expected 
applications of the MR-linac system is for liver patients. The MR 
imaging can provide daily excellent soft-tissue contrast (compared to 
CBCT) and the full quantification of organ and tumor motion. To 
